EP 1068186 A2 20010117 - PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE
Title (en)
PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE
Title (de)
3-PYRIDYLALKOXYAMINE ODER ARYLOXYALKYLAMINE DERIVATE ALS CHOLINERGISCHE AGONISTEN
Title (fr)
PREPARATIONS PHARMACEUTIQUES ET LEUR MODES D'UTILISATION
Publication
Application
Priority
- US 9904235 W 19990226
- US 5413098 A 19980402
Abstract (en)
[origin: WO9951216A2] Patients susceptible to or suffering from conditions and disorders, such as central nervous system disorders, are treated by administering to a patient in need thereof aryloxyalkylamines, including pyridyloxylalkylamines and phenoxyalkylamines, such as (3-(3-pyridyloxy)propyl)methylamine and (3-(5-bromo(3-pyridyloxy))propyl)methylamine.
IPC 1-7
IPC 8 full level
A61K 31/138 (2006.01); A61K 31/44 (2006.01); A61K 31/4406 (2006.01); A61P 25/00 (2006.01); A61P 43/00 (2006.01); C07D 213/65 (2006.01)
CPC (source: EP KR)
A61K 31/138 (2013.01 - EP); A61K 31/44 (2013.01 - EP); A61K 31/4406 (2013.01 - EP); A61K 31/505 (2013.01 - KR); A61P 25/00 (2017.12 - EP); A61P 43/00 (2017.12 - EP); C07D 213/65 (2013.01 - EP)
Citation (search report)
See references of WO 9951216A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9951216 A2 19991014; WO 9951216 A3 19991118; AU 2880699 A 19991025; BR 9907170 A 20001226; CA 2317572 A1 19991014; EP 1068186 A2 20010117; JP 2002510619 A 20020409; KR 20010052171 A 20010625; MX PA00009619 A 20060309; US 2001014691 A1 20010816; US 6166047 A 20001226; US 6441006 B2 20020827; US 6441007 B1 20020827
DOCDB simple family (application)
US 9904235 W 19990226; AU 2880699 A 19990226; BR 9907170 A 19990226; CA 2317572 A 19990226; EP 99909644 A 19990226; JP 2000541987 A 19990226; KR 20007008961 A 20000816; MX PA00009619 A 19990226; US 31732199 A 19990524; US 5413098 A 19980402; US 62899500 A 20000731